RIGEL PHARMACEUTICALS INC — Director's Dealing 2017

Jul 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2017-07-05

Reporting Person: Duliege Anne-Marie (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-05	Common Stock	S	5000	$2.6854	Disposed	0	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 10, 2016.

F2: The Reporting Person purchased these shares on 6/30/17 under the Employee Stock Purchase Plan.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.75, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the range set forth in footnote three (3) of this Form 4.